Clarus Corp (CLAR) stock
Close on Nov 12, 2026Market cap $197.95MP/E –Yield 1.93%
Earnings
Clarus's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Clarus's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 4, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | $71.20M | +2.7% | $0.09 | $0.15 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026after the close | $56.20M | +1.8% | $0.12 | $0.18 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026after the close | $61.90M | +2.5% | -$0.09 | $0.02 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 5, 2026after the close | $65.40M | -8.4% | -$0.81 | $0.09 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025after the close | $69.30M | +3.3% | -$0.04 | $0.05 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 31, 2025after the close | $55.20M | -2.3% | -$0.22 | -$0.03 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025after the close | $60.40M | -12.8% | -$0.14 | -$0.02 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 6, 2025after the close | $71.40M | -6.7% | -$1.71 | -$0.08 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 8, 2024after the close | $67.10M | -33.0% | -$0.08 | $0.05 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024after the close | $56.50M | -32.5% | -$0.14 | -$0.03 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024after the close | $69.30M | -28.9% | $0.57 | $0.00 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 7, 2024after the close | $76.50M | -26.6% | -$0.19 | -$0.07 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023after the close | $100.10M | -13.5% | -$0.03 | $0.16 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 7, 2023after the close | $83.70M | -27.2% | -$0.06 | $0.11 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 1, 2023after the close | $97.40M | -14.0% | $0.04 | $0.18 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 27, 2023after the close | $104.20M | -11.8% | -$2.20 | $0.20 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022after the close | $115.70M | +6.1% | $0.07 | $0.26 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 1, 2022after the close | $114.90M | – | $0.09 | $0.33 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 9, 2022after the close | $113.30M | – | $0.13 | $0.37 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 7, 2022after the close | $118.20M | – | $0.36 | $0.45 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 8, 2021after the close | $109.00M | – | $0.13 | $0.50 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 2, 2021after the close | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | May 10, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 1, 2021before the open | – | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Oct 21, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Clarus's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| sales | Q4 FY2026 | $62.00M – $66.00M | – | New | Nov 5, 2026 |
| adjusted EBITDAnon-GAAP | Q4 FY2026 | $3.00M | – | New | Nov 5, 2026 |
| sales | FY2026 | $251.00M – $255.00M | – | New | Nov 5, 2026 |
| sales | FY2026 | $245.00M – $255.00M | $245.00M – $255.00M | Reaffirmed | Aug 6, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $15.00M – $17.00M | – | New | Nov 5, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $12.00M – $13.00M | $3.00M – $5.00M | Raised | Aug 6, 2026 |
| free cash flownon-GAAP | FY2026 | $6.00M | $3.00M – $4.00M | Raised | Aug 6, 2026 |
| Capital expenditures | FY2026 | $6.00M – $7.00M | – | New | Nov 5, 2026 |
| Capital expenditures | FY2026 | $6.00M – $7.00M | $6.00M – $7.00M | Reaffirmed | Aug 6, 2026 |
| adjusted EBITDA marginnon-GAAP | FY2026 | 6.3% | – | New | Nov 5, 2026 |
| adjusted EBITDA marginnon-GAAP | FY2026 | 5% | 1.6% | Raised | Aug 6, 2026 |
Guidance vs results
The last range Clarus gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Revenue | $66.00M – $68.00M | $71.20M | Above range |
| Q2 FY2026 | Revenue | $51.00M – $53.00M | $56.20M | Above range |
Guidance history
Every forecast Clarus put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Capital expenditures | FY2026 | $6.00M – $7.00M | New |
| Nov 5, 2026 | adjusted EBITDA | Q4 FY2026 | $3.00M | New |
| Nov 5, 2026 | adjusted EBITDA | FY2026 | $15.00M – $17.00M | New |
| Nov 5, 2026 | adjusted EBITDA margin | FY2026 | 6.3% | New |
| Nov 5, 2026 | sales | Q4 FY2026 | $62.00M – $66.00M | New |
| Nov 5, 2026 | sales | FY2026 | $251.00M – $255.00M | New |
| Aug 6, 2026 | Capital expenditures | FY2026 | $6.00M – $7.00M | Reaffirmed |
| Aug 6, 2026 | adjusted EBITDA | FY2026 | $12.00M – $13.00M | Raised |
| Aug 6, 2026 | adjusted EBITDA | Q3 FY2026 | $3.00M | New |
| Aug 6, 2026 | free cash flow | FY2026 | $6.00M | Raised |
| Aug 6, 2026 | adjusted EBITDA margin | FY2026 | 5% | Raised |
| Aug 6, 2026 | sales | FY2026 | $245.00M – $255.00M | Reaffirmed |
| Aug 6, 2026 | sales | Q3 FY2026 | $66.00M – $68.00M | New |
| May 7, 2026 | Capital expenditures | FY2026 | $6.00M – $7.00M | Reaffirmed |
| May 7, 2026 | adjusted EBITDA | FY2026 | $3.00M – $5.00M | Lowered |
| May 7, 2026 | adjusted EBITDA | Q2 FY2026 | -$3.00M | New |
| May 7, 2026 | adjusted EBITDA margin | FY2026 | 1.6% | Lowered |
| May 7, 2026 | sales | FY2026 | $245.00M – $255.00M | Lowered |
| May 7, 2026 | sales | Q2 FY2026 | $51.00M – $53.00M | New |
| Mar 5, 2026 | capital expenditures | FY2026 | $6.00M – $7.00M | New |
| Mar 5, 2026 | adjusted EBITDA | FY2026 | $9.00M – $11.00M | New |
| Mar 5, 2026 | free cash flow | FY2026 | $3.00M – $4.00M | New |
| Mar 5, 2026 | adjusted EBITDA margin | FY2026 | 3.8% | New |
| Mar 5, 2026 | sales | FY2026 | $255.00M – $265.00M | New |
| Mar 6, 2025 | capital expenditures | FY2025 | $4.00M – $5.00M | New |
| Mar 6, 2025 | adjusted EBITDA | FY2025 | $14.00M – $16.00M | New |
| Mar 6, 2025 | free cash flow | FY2025 | $8.00M – $10.00M | New |
| Mar 6, 2025 | adjusted EBITDA margin | FY2025 | 5.9% | New |
| Mar 6, 2025 | sales | FY2025 | $250.00M – $260.00M | New |
| Nov 7, 2024 | capital expenditures | FY2024 | $5.00M – $6.00M | Lowered |
| Nov 7, 2024 | adjusted EBITDA | FY2024 | $7.00M – $9.00M | Lowered |
| Nov 7, 2024 | free cash flow | FY2024 | -$8.00M – -$6.00M | Lowered |
| Nov 7, 2024 | adjusted EBITDA margin | FY2024 | 3% | Lowered |
| Nov 7, 2024 | sales | FY2024 | $260.00M – $266.00M | Lowered |
| Aug 1, 2024 | capital expenditures | FY2024 | $6.00M – $7.00M | New |
| Aug 1, 2024 | adjusted EBITDA | FY2024 | $11.00M – $14.00M | Lowered |
| Aug 1, 2024 | adjusted free cash flow | FY2024 | $7.00M – $9.00M | Lowered |
| Aug 1, 2024 | adjusted EBITDA margin | FY2024 | 4.5% | Lowered |
| Aug 1, 2024 | sales | FY2024 | $270.00M – $280.00M | New |
| May 2, 2024 | capital expenditures | FY2024 | $4.00M – $5.00M | Reaffirmed |
| May 2, 2024 | adjusted EBITDA | FY2024 | $16.00M – $18.00M | Reaffirmed |
| May 2, 2024 | free cash flow | FY2024 | $18.00M – $20.00M | Reaffirmed |
| May 2, 2024 | adjusted EBITDA margin | FY2024 | 6.2% | Reaffirmed |
| May 2, 2024 | sales | FY2024 | $270.00M – $280.00M | Reaffirmed |
| Mar 7, 2024 | capital expenditures | FY2024 | $4.00M – $5.00M | New |
| Mar 7, 2024 | adjusted EBITDA | FY2024 | $16.00M – $18.00M | New |
| Mar 7, 2024 | free cash flow | FY2024 | $18.00M – $20.00M | New |
| Mar 7, 2024 | adjusted EBITDA margin | FY2024 | 6.2% | New |
| Mar 7, 2024 | sales | FY2024 | $270.00M – $280.00M | New |
| Nov 7, 2023 | capital expenditures | FY2023 | $6.00M | New |
| Nov 7, 2023 | adjusted EBITDA | FY2023 | $33.00M – $35.00M | Lowered |
| Nov 7, 2023 | free cash flow | FY2023 | $20.00M – $22.00M | Lowered |
| Nov 7, 2023 | sales | FY2023 | $364.00M – $368.00M | New |
| Aug 7, 2023 | capital expenditures | FY2023 | $6.50M – $7.50M | Lowered |
| Aug 7, 2023 | adjusted EBITDA | FY2023 | $42.00M – $50.00M | Lowered |
| Aug 7, 2023 | free cash flow | FY2023 | $30.00M – $35.00M | Lowered |
| Aug 7, 2023 | sales | FY2023 | $385.00M – $400.00M | Lowered |
| May 1, 2023 | capital expenditures | FY2023 | $7.00M – $8.00M | Reaffirmed |
| May 1, 2023 | adjusted EBITDA | FY2023 | $60.00M | Reaffirmed |
| May 1, 2023 | free cash flow | FY2023 | $35.00M – $40.00M | Reaffirmed |
| May 1, 2023 | adjusted EBITDA margin | FY2023 | 14.3% | New |
| May 1, 2023 | sales | FY2023 | $420.00M | Reaffirmed |
| Feb 27, 2023 | capital expenditures | FY2023 | $7.00M – $8.00M | New |
| Feb 27, 2023 | adjusted EBITDA | FY2023 | $60.00M | New |
| Feb 27, 2023 | free cash flow | FY2023 | $35.00M – $40.00M | New |
| Feb 27, 2023 | sales | FY2023 | $420.00M | New |
| Nov 7, 2022 | capital expenditures | FY2022 | $8.00M | Lowered |
| Nov 7, 2022 | adjusted EBITDA | FY2022 | $64.00M | Lowered |
| Nov 7, 2022 | free cash flow | FY2022 | -$5.00M – $0 | Lowered |
| Nov 7, 2022 | sales | FY2022 | $445.00M | Lowered |
| Aug 1, 2022 | capital expenditures | FY2022 | $9.00M | New |
| Aug 1, 2022 | adjusted EBITDA | FY2022 | $78.00M | Reaffirmed |
| Aug 1, 2022 | free cash flow | FY2022 | $30.00M – $40.00M | Lowered |
| Aug 1, 2022 | sales | FY2022 | $470.00M | New |
| May 9, 2022 | capital expenditures | FY2022 | $9.00M | Reaffirmed |
| May 9, 2022 | adjusted EBITDA | FY2022 | $78.00M | Reaffirmed |
| May 9, 2022 | free cash flow | FY2022 | $50.00M – $60.00M | Reaffirmed |
| May 9, 2022 | sales | FY2022 | $470.00M | Reaffirmed |
| Mar 7, 2022 | capital expenditures | FY2022 | $9.00M | New |
| Mar 7, 2022 | adjusted EBITDA | FY2022 | $78.00M | New |
| Mar 7, 2022 | free cash flow | FY2022 | $50.00M – $60.00M | New |
| Mar 7, 2022 | adjusted EBITDA margin | FY2022 | 16.5% | New |
| Mar 7, 2022 | sales | FY2022 | $470.00M | New |
| Nov 8, 2021 | Capital expenditures | FY2021 | $8.50M | New |
| Nov 8, 2021 | adjusted EBITDA | FY2021 | $57.00M | New |
| Nov 8, 2021 | sales | FY2021 | $362.50M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Clarus filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- Results
- Results
See a number that looks wrong?